Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Tissue diagnostic procedures are majorly used for cancer diagnosis. Some of the major tissue diagnostic tests are immunochemistry (IHC), haematoxylin and eosin (H&E), and in situ hybridization (ISH)
Scope of the Report:
This report studies the Tissue Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tissue Diagnostics market by product type and applications/end industries.
Growing prevalence of cancer coupled with growing demand for personalized medicine are anticipated to propel the growth of the tissue diagnostic market over the forecast period. Tissue diagnostic involves monitoring, prognosis, and management of different stages of cancer, especially prostate cancer, gastric cancer and breast cancer. Furthermore, rising global geriatric population base, increasing demand for cost-effective and safe treatment and growing expenditure in the healthcare sector are other vital drivers of the tissue diagnostic market.
The Americas accounted for the major share in the cancer diagnostics market in 2017. The Americas are the highest revenue generator due to the growing demand for digital pathology, lab automation and robotics and molecular profiling.
The global Tissue Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tissue Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott
Agilent Technologies
Danaher
F. Hoffmann-La Roche
Sakura Finetek
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diagnostic Consumables
Diagnostic Instruments
Market Segment by Applications, can be divided into
Hospitals
Diagnostic Laboratories
Others
Scope of the Report:
This report studies the Tissue Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tissue Diagnostics market by product type and applications/end industries.
Growing prevalence of cancer coupled with growing demand for personalized medicine are anticipated to propel the growth of the tissue diagnostic market over the forecast period. Tissue diagnostic involves monitoring, prognosis, and management of different stages of cancer, especially prostate cancer, gastric cancer and breast cancer. Furthermore, rising global geriatric population base, increasing demand for cost-effective and safe treatment and growing expenditure in the healthcare sector are other vital drivers of the tissue diagnostic market.
The Americas accounted for the major share in the cancer diagnostics market in 2017. The Americas are the highest revenue generator due to the growing demand for digital pathology, lab automation and robotics and molecular profiling.
The global Tissue Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tissue Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott
Agilent Technologies
Danaher
F. Hoffmann-La Roche
Sakura Finetek
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diagnostic Consumables
Diagnostic Instruments
Market Segment by Applications, can be divided into
Hospitals
Diagnostic Laboratories
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
